D-0461-2022 Class II Terminated

Recalled by Teva Pharmaceuticals USA — Parsippany, NJ

Recall Details

Product Type
Drugs
Report Date
February 9, 2022
Initiation Date
January 18, 2022
Termination Date
December 21, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6205 100-count bottles

Product Description

Doxylamine Succinate and Pyridoxine Hydrochloride Delayed-Release Tablets 10 mg/10 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 007045 USA, NDC 0591-2132-01

Reason for Recall

Failed Dissolution Specification: Dissolution results are below specification limits for the active ingredient

Distribution Pattern

Nationwide in the USA

Code Information

Lot# 100025842, 100028023, Exp Date 08/2023